IL98033A - Pharmaceutical compositions including a non-steroidal anti-inflammatory drug and prostaglandin - Google Patents
Pharmaceutical compositions including a non-steroidal anti-inflammatory drug and prostaglandinInfo
- Publication number
- IL98033A IL98033A IL9803391A IL9803391A IL98033A IL 98033 A IL98033 A IL 98033A IL 9803391 A IL9803391 A IL 9803391A IL 9803391 A IL9803391 A IL 9803391A IL 98033 A IL98033 A IL 98033A
- Authority
- IL
- Israel
- Prior art keywords
- prostaglandin
- pharmaceutical composition
- core
- nsaid
- mantle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51835390A | 1990-05-03 | 1990-05-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL98033A0 IL98033A0 (en) | 1992-06-21 |
IL98033A true IL98033A (en) | 1995-07-31 |
Family
ID=24063571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9803391A IL98033A (en) | 1990-05-03 | 1991-05-02 | Pharmaceutical compositions including a non-steroidal anti-inflammatory drug and prostaglandin |
Country Status (15)
Country | Link |
---|---|
US (2) | US5601843A (da) |
EP (1) | EP0527887B1 (da) |
AT (1) | ATE121625T1 (da) |
AU (1) | AU7876491A (da) |
CA (1) | CA2082944C (da) |
DE (1) | DE69109286T2 (da) |
DK (1) | DK0527887T3 (da) |
ES (1) | ES2071312T3 (da) |
GR (1) | GR3015939T3 (da) |
IE (1) | IE68596B1 (da) |
IL (1) | IL98033A (da) |
NZ (1) | NZ238024A (da) |
PT (1) | PT97562B (da) |
WO (1) | WO1991016895A1 (da) |
ZA (1) | ZA913353B (da) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2071312T3 (es) * | 1990-05-03 | 1995-06-16 | Searle & Co | Composicion farmaceutica. |
FI93924C (fi) * | 1991-09-17 | 1995-06-26 | Martti Lauri Antero Marvola | Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi |
US5324746A (en) * | 1993-02-12 | 1994-06-28 | Mckee Rex N | Method of treating damaged mucosal and epithelial tissues with misoprostol |
DE4341442C2 (de) * | 1993-12-04 | 1998-11-05 | Lohmann Therapie Syst Lts | Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung |
AU6981996A (en) * | 1995-09-27 | 1997-04-17 | Merck Frosst Canada Inc. | Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor |
US6623759B2 (en) * | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
US6103765A (en) | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
KR20010021625A (ko) | 1997-07-09 | 2001-03-15 | 추후보정 | 개선된 남성발기 기능장애 치료방법 및 그 조성물 |
CA2241342C (en) * | 1998-06-15 | 2000-02-08 | Bernard Charles Sherman | Pharmaceutical tablets comprising an nsaid and a prostaglandin |
GB9814215D0 (en) * | 1998-07-01 | 1998-09-02 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
US6319519B2 (en) | 1998-07-07 | 2001-11-20 | Norton Healthcare Ltd. | Anti-inflammatory pharmaceutical formulations |
GB9819685D0 (en) * | 1998-09-10 | 1998-11-04 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
US6387410B1 (en) | 1998-09-10 | 2002-05-14 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
US6514525B2 (en) | 1998-09-10 | 2003-02-04 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
SE9803761D0 (sv) * | 1998-11-04 | 1998-11-04 | Synphora Ab | Method to avoid increased iridial pigmentation during prostaglandin treatment |
US7429407B2 (en) * | 1998-12-30 | 2008-09-30 | Aeromatic Fielder Ag | Process for coating small bodies, including tablets |
CA2259727A1 (en) * | 1999-01-18 | 2000-07-18 | Bernard Charles Sherman | A two-layer pharmaceutical tablet comprising an nsaid and misoprostol |
US6183779B1 (en) | 1999-03-22 | 2001-02-06 | Pharmascience Inc. | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
CA2277407A1 (en) | 1999-07-14 | 2001-01-14 | Bernard Charles Sherman | Pharmaceutical tablet comprising an nsaid and misoprostol |
AU7537000A (en) * | 1999-10-01 | 2001-05-10 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
US6761895B2 (en) * | 2000-04-17 | 2004-07-13 | Yamanouchi Pharmaceutical Co., Ltd. | Drug delivery system for averting pharmacokinetic drug interaction and method thereof |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
WO2004064815A1 (en) * | 2003-01-21 | 2004-08-05 | Smartrix Technologies Inc. | Oral dosage formulation |
ATE366105T1 (de) * | 2003-03-03 | 2007-07-15 | Sprl Franpharma | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nsaid und einen prostaglandin |
WO2004091579A1 (en) * | 2003-04-16 | 2004-10-28 | Pharmacia Corporation | Stabilized prostaglandin formulation |
US7241746B2 (en) | 2003-08-06 | 2007-07-10 | Regena Therapeutics, Lc | Method and composition for treating periodontal disease |
US20050163847A1 (en) * | 2004-01-21 | 2005-07-28 | Andrx Pharmaceuticals, Llc | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug |
US20060024368A1 (en) * | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
US20060073202A1 (en) * | 2004-10-05 | 2006-04-06 | Rocca Jose G | Dual component medicament delivery system |
US20080020040A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Unit dose form for administration of ibuprofen |
US20080021078A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
US8067033B2 (en) * | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
US20150224056A1 (en) * | 2006-07-18 | 2015-08-13 | Horizon Pharma Usa, Inc. | Pharmaceutical compositions of ibuprofen and famotidine |
EP2063873A2 (en) * | 2006-08-31 | 2009-06-03 | Horizon Therapeutics, Inc. | Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
EP2167048B1 (en) | 2007-05-30 | 2016-10-26 | Wockhardt Limited | A novel tablet dosage form |
CA2736547C (en) | 2008-09-09 | 2016-11-01 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
EP2210595A1 (en) | 2009-01-14 | 2010-07-28 | LEK Pharmaceuticals d.d. | Active coating of pharmaceutical dosage forms |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
EA021112B1 (ru) * | 2009-06-25 | 2015-04-30 | Поузен Инк. | Способ лечения боли и/или воспаления у пациента, нуждающегося в аспириновой терапии |
MX2014007935A (es) | 2011-12-28 | 2014-11-14 | Pozen Inc | Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico. |
KR20180128452A (ko) * | 2016-04-11 | 2018-12-03 | 유니버시티 오브 유타 리서치 파운데이션 | Nsaid-유도된 심혈관, 뇌혈관, 또는 신혈관 부작용을 치료하는 방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2135881A (en) * | 1983-03-02 | 1984-09-12 | Erba Farmitalia | Method and pharmaceutical compositions for inhibiting or reducing gastrointestinal side effects of non-steroidal anti-inflammatory drugs |
IT1190400B (it) * | 1985-10-04 | 1988-02-16 | Istituto Biochimico Italiano | Derivati dell'acido 19,20-bis,nor-prostanoico ad attivita' antiulcera e anoressivca,procedimento per la loro preparazione e composizioni farmaceutiche |
US4707495A (en) * | 1985-10-28 | 1987-11-17 | Ortho Pharmaceutical | Peptic ulcer treatment method |
US4975283A (en) * | 1985-12-12 | 1990-12-04 | Bristol-Myers Squibb Company | Stabilized enteric coated aspirin granules and process for preparation |
DE3603576A1 (de) * | 1986-02-06 | 1987-08-13 | Code Kaffee Handel | Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz |
JPH01139528A (ja) * | 1987-11-24 | 1989-06-01 | Showa Denko Kk | 抗潰瘍剤 |
ES2071312T3 (es) * | 1990-05-03 | 1995-06-16 | Searle & Co | Composicion farmaceutica. |
-
1991
- 1991-05-01 ES ES91909572T patent/ES2071312T3/es not_active Expired - Lifetime
- 1991-05-01 DE DE69109286T patent/DE69109286T2/de not_active Expired - Lifetime
- 1991-05-01 DK DK91909572.9T patent/DK0527887T3/da active
- 1991-05-01 EP EP91909572A patent/EP0527887B1/en not_active Expired - Lifetime
- 1991-05-01 AT AT91909572T patent/ATE121625T1/de not_active IP Right Cessation
- 1991-05-01 AU AU78764/91A patent/AU7876491A/en not_active Abandoned
- 1991-05-01 CA CA002082944A patent/CA2082944C/en not_active Expired - Lifetime
- 1991-05-01 WO PCT/US1991/002980 patent/WO1991016895A1/en active IP Right Grant
- 1991-05-02 NZ NZ238024A patent/NZ238024A/xx unknown
- 1991-05-02 IE IE148691A patent/IE68596B1/en not_active IP Right Cessation
- 1991-05-02 IL IL9803391A patent/IL98033A/en not_active IP Right Cessation
- 1991-05-03 PT PT97562A patent/PT97562B/pt not_active IP Right Cessation
- 1991-05-03 ZA ZA913353A patent/ZA913353B/xx unknown
-
1994
- 1994-07-18 US US08/276,299 patent/US5601843A/en not_active Expired - Lifetime
-
1995
- 1995-04-27 GR GR950400874T patent/GR3015939T3/el unknown
-
1997
- 1997-02-03 US US08/794,027 patent/US5698225A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2071312T3 (es) | 1995-06-16 |
EP0527887A1 (en) | 1993-02-24 |
EP0527887B1 (en) | 1995-04-26 |
CA2082944C (en) | 1998-11-24 |
GR3015939T3 (en) | 1995-07-31 |
US5698225A (en) | 1997-12-16 |
IE911486A1 (en) | 1991-11-06 |
IL98033A0 (en) | 1992-06-21 |
IE68596B1 (en) | 1996-06-26 |
PT97562A (pt) | 1992-02-28 |
ATE121625T1 (de) | 1995-05-15 |
CA2082944A1 (en) | 1991-11-04 |
DE69109286D1 (de) | 1995-06-01 |
DK0527887T3 (da) | 1995-07-03 |
NZ238024A (en) | 1993-08-26 |
WO1991016895A1 (en) | 1991-11-14 |
ZA913353B (en) | 1993-04-28 |
PT97562B (pt) | 1998-08-31 |
DE69109286T2 (de) | 1995-09-28 |
US5601843A (en) | 1997-02-11 |
AU7876491A (en) | 1991-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5601843A (en) | Pharmaceutical tablet composition | |
US5213807A (en) | Pharmaceutical composition containing ibuprofen and a prostaglandin | |
US6537582B2 (en) | Anti-inflammatory pharmaceutical formulations | |
EP0493408B1 (en) | Oral anticoagulant/platelet inhibitor low dose formulation | |
HU199677B (en) | Process for producing retard pharmaceutical composition | |
US5015481A (en) | Stabilized pharmaceutical admixture composition | |
JPH0774155B2 (ja) | 消炎作用を示す計画的放出型経口投与用医薬製剤 | |
JP3018160B2 (ja) | 月経困難症及び/又は月経前症候群の軽減用薬剤 | |
EP1462098A1 (en) | Stabilised pharmaceutical composition comprising a non-steroidal anti-inflammatory agent and a prostaglandin | |
NZ238023A (en) | Pharmaceutical composition comprising a core of ibuprofen, an intermediate coating and an outer coating of a prostaglandin | |
SK284728B6 (sk) | Farmaceutický prostriedok obsahujúci ibuprofen a domperidone na ošetrovanie migrény | |
AU707467B2 (en) | Nasal administration of agents for treatment of delayed onset emesis | |
US5576331A (en) | Agent for preventing and treating disturbances of intestinal mucous membrane | |
CA2387288A1 (en) | Anti-inflammatory pharmaceutical formulations | |
US20050171119A1 (en) | Pharmaceutical formulations with modified release | |
CA2514022A1 (en) | Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders | |
AU2003288041A1 (en) | Tablet comprising efletirizine and pseudoephedrine | |
JPWO2020247603A5 (da) | ||
JP2009132734A (ja) | 抗感冒剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |